Simon C. Lowry
SVP, R&D, CMO · Emergent BioSolutions Inc.
Individual
- 2024
- May 1, 2026
- 4
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Simon C. Lowry files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Donald W. Degolyer - $444K in EBS purchases and sales in the last 12 months
- Sujata Tyagi Dayal - $201K in EBS purchases and sales in the last 12 months
- Kathryn C. Zoon - $144K in EBS purchases and sales in the last 12 months
- Keith Katkin - $128K in EBS purchases and sales in the last 12 months
- Paul Anthony Williams - $79K in EBS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Simon C. Lowry?
Simon C. Lowry is a corporate insider, tracked as SVP, R&D, CMO of Emergent BioSolutions Inc. (EBS). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Simon C. Lowry last file a Form 4?
The most recent primary Form 4 on record is dated 1 May 2026, one of 4 filings going back to 2024.
